Search

everythinglearnresearchcommunity

for

Search:↓

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Androgens reduce macrophage receptor expression, affecting immune response, while antiandrogens counteract this effect.

Finasteride may be a promising treatment for recurrent priapism in sickle cell anemia.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Androgenetic alopecia is a common cause of hair loss, with treatments like minoxidil and hair transplantation available, and new therapies are being developed.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

The document concludes that individualized treatments for hair issues are effective, certain hair changes can indicate neurocutaneous diseases, specific lotions improve skin health, laser hair removal works but needs more study on long-term effects, men's cosmetics are diverse, peeling is effective but can have side effects, and facial pigmentation is often due to overactive skin cells.

Higher levels of 3α-diol G are linked to more severe female pattern hair loss.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

New hormonal therapies can help treat advanced prostate cancer but may cause testicular issues.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.

Antiandrogen therapy may help treat hidradenitis suppurativa.

The study suggests hormonal factors may play a role in Frontal Fibrosing Alopecia and that treatments like oral antiandrogens and steroids could be beneficial.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

The cream with turmeric and ginger extracts can potentially reduce underarm hair growth effectively.

Equisetum debile extract, especially the ethyl acetate type, may be a promising natural ingredient for anti-hair loss products.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.